Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-24-003452

President and CEO sold 15,000 shares at $18.19 ($272,871)

  • President and CEO acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mills Kenneth T. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-15 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $3.76 $56,400 423,035 D
2024-04-15 Sale : show line 2 in the form 10b5-1 −15,000 $18.19 $272,871 408,035 D
Open-market sales · 15,000 sh · avg $18.19 · $272,871

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-15 Exercise or conversion : show line 3 in the form 10b5-1 Stock Options (Right to Buy) −15,000 96,354 D
Loading xslF345X05/primarydocument.xml…